Sheep lice and dog earaches: The Asia-Pacific Tipline for 10 July 2020

It seems that Elanco Animal Health’s strategy of divesting the rights to several animal treatments to push its far-bigger acquisition of Bayer’s animal health business has paid off. Those already planned divestitures featured heavily in yesterday’s clearances of the tie-up in Australia and New Zealand.

Get unlimited access to all Global Competition Review content